Conventional treatment of myeloma Athanasios Zomas, Meletios A Dimopoulos

Myeloma is a relatively common haematologic malignancy, with an annual incidence in the United States of approximately 13 000 patients. An increasing number of patients are now diagnosed by chance (routine evaluation), and should not be treated unless there is evidence of an imminent complication or demonstration of progressive disease. However, most patients do present with symptoms and signs related to myeloma, and require prompt treatment.